Skip to content

Alligator Bioscience

sv

About Alligator
Research & development
Corporate governance
Investors
News
Contact

SV

Start > Events > 2nd Annual Next Gen Immuno-Oncology Congress, London

2nd Annual Next Gen Immuno-Oncology Congress, London

13 Mar 2018 — 14 Mar 2018

About

Alligator develops antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company is active in the early stages of drug development, from idea to clinical phase II studies.

Links

About Alligator
Research and development
Corporate governance
Investors
News
Contact

Contact

Alligator Bioscience AB
Medicon Village
Scheelevägen 2
SE-223 81 Lund
Sweden

Phone: + 46 (0)46 540 82 00

info@alligatorbioscience.com
ir@alligatorbioscience.com

Subscribe

Subscribe to get our pressreleases by email.

SUBSCRIBE

We use cookies for administering, monitoring and optimizing the website, and for analytical purposes, in accordance with what is stated in our cookie policy.I agree I do not agree

Återkalla cookies